Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

LENZLENZ
Showing 8 of 10 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in LENZ THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 564,662 shares of LENZ (LENZ THERAPEUTICS INC), worth $3.2M as of 2026-Q2. The position was increased (+7.6% shares). LENZ represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$3.2M

Current Shares

564,662

Total Value Change

-$4.8M

Total Shares Change

+226,638

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
564,662
+7.6%
$3.2M0.0%$5.68
29
2026-Q1
Increased
524,574
+13.8%
$4.8M0.0%$13.15
31
2025-Q4
Increased
461,075
+1.4%
$7.4M0.0%$16.12
28
2025-Q3
Increased
454,896
+9.3%
$21.2M0.0%$44.89
31
2025-Q2
Increased
416,122
+15.5%
$12.2M0.0%$30.18
32
2025-Q1
Increased
360,392
+7.9%
$9.3M0.0%$25.64
30
2024-Q4
Decreased
334,026
-1.2%
$9.6M0.0%$30.07
0
2024-Q3
Decreased
338,024
-6.1%
$8M0.0%$24.04
0

Other major holders of LENZ: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used